ECP在气道变应性疾病中的应用进展

陈以标; 刘月辉

doi:10.13201/j.issn.1001-1781.2016.18.016

ECP在气道变应性疾病中的应用进展

陈以标,
刘月辉^,

- 南昌大学第二附属医院耳鼻咽喉头颈外科(南昌, 330006)

详细信息

通讯作者: 刘月辉,E-mail:liuyuehuiclark@21cn.com

中图分类号: R739.65

收稿日期: 2016-03-01

The application of eosinophil cationic protein on inflammatory disease of airway

CHEN Yibiao,
LIU Yuehui^,

More Information

Corresponding author: LIU Yuehui, E-mail: liuyuehuiclark@21cn.com

Received Date: 01 March 2016

摘要

- 嗜酸粒细胞 /
- 嗜酸粒细胞阳离子蛋白 /
- 哮喘 /
- 鼻炎 /
- 变应性
Abstract: Eosinophil cationic protein(ECP)is a heterogeneous molecule originating from activated eosinophil granulocytes.Airway allergic diseases such as allergic rhinitis and asthma are closely related eosinophils that Infiltrate local tissue.ECP can be actively used in the diagnosis of allergic disease,curative effect evaluations as a biomarker.The origin and the biology function of ECP as well as its relations with the infection are introduced,espcially,the relationship between ECP and ashma、allergic rhinitis are also addressed.
- eosinophil /
- eosinophil cationic protein /
- ashma /
- rhinitis /
- allergic

HTML全文

参考文献(28)

[1]	BOIX E,TORRENT M.The antipathogen activities of eosinophil cationic protein[J].Curr Pharm Biotechnol,2008,9:141-152.
[2]	BYSTROM J,AMIN K,DAVID B B,et al.A nalysing the eosinophilcationic protein-a clue to the function of the eosinophil granulocyte[J].Respir Res,2011,12:10-10.
[3]	DAVID P,MARC T.Two human host defense ribonucleases against mycobacteria,the eosinophil cationic protein(RNase 3)and rNase 7[J].Antimicrobial Agents Chemother,2013,57:3797-3805.
[4]	HUNG T J,TOMIYA N,CHANG T H,et al.Functional characterization of ECP-heparin interaction:a novel molecular model[J].PLoS One,2013,8:e82585.
[5]	DYER K D,ROSENBERG H F.The RNase a super family:generation of diversity and innate host defense[J].Mol Divers,2006,10:585-597.
[6]	ESTER B,VIVIAN A,SALAZAR M T.Structural determinants of the eosinophil cationic protein antimicrobial activity[J].Biol Chem,2012,393:801-815.
[7]	JONAS B,KAWA A,DAVID B B.Analysing the eosinophil cationic protein-a clue to the function of the eosinophil granulocyte[J].Respir Res,2011,12:1-20.
[8]	MALM-ERJEFALT M,GREIFF L.Circulating eosino phils in asthma,allergic rhinitis,and atopic dermatitis lack morphological signs of degranulation[J].Clin Exp Allergy,2005,35:1334-1340.
[9]	LEGRAND F,DRISS V.Human eosinophils exertT-NF-alpha and granzyme A-mediated tumoricidal activity toward colon carcinoma cells[J].Immunol,2010,185:7443-7451.
[10]	SUN D I,JOO Y H,AUO H J.Clinical significance of eosinophiliccationic protein levels in nasal secretions of patients with nasal polyposis[J].Eur Arch Otorhinolaryngol,2009,266:981-986.
[11]	STEPHEN J.FOWLER G T,ROBERT N.High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma[J].Allergy Clin Immunol,2015,135:822-824.
[12]	ZADEH M H,BANTHIA V,ANAND V K,et al.Significance of eos inophilia in chronic rhinosinusitis[J].Am J Rhinol,2002,16:313-317.
[13]	SATO T,SOGA Y,YAMAGUCHI T,et al.Cytokine expression in human dermal fibroblasts stimulated with eosinophil cationic protein measured by protein array[J].Asian Pac Allergy Immunol,2013,31:271-276.
[14]	JUNG Y G,KIM K H,K IM H Y,et al.Predictive capabilities of serum eosinophil cationic protein,percentage of eosinophils and total immunoglobulin E in allergic rhinitis without bronchial asthma[J].J Int Med Res,2011,39:2209-2216.
[15]	BADAR A,SAEED W,HUSSAIN M M,ASLAMM.Correlation of eosinophil cationic protein with severity of asthma[J].J Ayub Med Coll Abbottabad,2004,16:66-71.
[16]	ZAGAI U,DADFAR E,LUNDANL J,et al.Eosinophil cationic protein stimulates TGF-beta1release by huaman lung fibroblasts in vitro[J].Inflammation,2007,30:153-160.
[17]	NIELSEN L P C,PETERSON G B,DAH R.Serum eosinophil granule proteins predict asthma risk in allergic rhinitis[J].Allergy,2009,64:733-737.
[18]	MARCUCCI F,SENSI L,DICARA G,et al.Threeyear follow-up of clinical and inflammation parameters in children monosensi ized to mites undergoing sublingual immunotherapy[J].Pediatr Allergy Immunol,2005,16:519-526.
[19]	CHOI S H,KIM D K,YU J,et al.Bronchial responsiveness tomethacholine and adenosine 5,2monphosphatein young children with ashma:their relationship with blood eosinophilsand serum eosinophil cationic protein[J].Allergy,2007,62:1119-1124.
[20]	MARCO R,MARCON A,JARVIS D,et al.European community respiratory health survey therapy group.Prognostic factors of asthma severity:a 9-year international prospective cohort study[J].Allergy Clin Immunol,2006,117:1249-1256.
[21]	KOH Y Y,KANG H,KIM C K.Ratio of serum eosinophil cationic protein/blood eosinophil counts in children with asthma:comparison between acute exacerbation and clinical remission[J].Allergy Asthma Proc,2003,24:269-274.
[22]	PREHN A,SEGER R A,TORRESANI T,et al.E-valuation of a clinical algorithm involving serum eosinophil cationic protein for guiding the anti-inflammatory treatment of bronchial asthma in childhood[J].Pediatr Allergy Immunol,2000,11:87-94.
[23]	WOLTHERS O D,HEUCK C.Impact of age and administration regimens on the suppressive effect of inhaled glucocorticoids on eosinophil markers in children with asthma.Pediatric Asthma[J].Allergy Immunol,2004,17:45-51.
[24]	MUNTHE KAAS M C,GETSEN J,CARLSEN KH,et al.Eosinophilcationic Protein(ECP)polymorphilcationic and association withasthma,s-ECP leveks and related Phenotypes[J].Allergy,2007,62:429-436.
[25]	CIANCHETTI S,BACCI E,RUOCCO L,et al.Are sputum eosinophil cationic protein and eosinophils differently associated with clinical and functional findings of asthma[J]?Clin Exp Allergy,2014,44:673-680.
[26]	MEYER P,PERSSON C G,ANDERSSON M,et al.Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis[J].Eur Respir J,1999,13:663-667.
[27]	CHOI K M,KIM J H,CHO G J,et al.Effect of exercise training on plasma visfatin and eotaxin levels[J].Eur Endocrinol,2007,157:437-442.
[28]	KAMPE M,LAMPINEN M,STOLT I,et al.PI3-kinase regulates eosinophil and neutrophil degranulation in patients with allergic rhinitis and allergic asthma irrespective of allergen challenge model[J].Inflammation,2012,35:230-239.